European Archives - Page 976 of 981 - European Medical Journal

EMJ Respiratory 2013

It gives me great pleasure to welcome you to the debut edition of EMJ – Respiratory. This journal is our biggest to date, and includes the EMJ…

Poor Asthma Control, Device Handling and Phenotype

The aim of this symposium is to discuss the impact of poor treatment and poor inhaler technique on asthma outcomes. In addition, the symposium will…

Long-Term Non-Invasive Ventilation (NIV) for COPD Patients with Chronic Respiratory Failure

Chronic obstructive pulmonary disease (COPD) is a major health issue worldwide, with disease burden, healthcare costs, and mortality rates all…

Effectiveness of Inhaler Devices in Adult Asthma and COPD

Inhalation therapy remains the cornerstone of treatment for bronchial diseases. Despite being pharmacologically efficacious, currently available inhaled…

Bronchoscopic Nitinol Coil Implantation: A New Lung Volume Reduction Strategy in COPD

Emphysema is a progressive, debilitating disease characterised by irreversible destruction of lung tissue. The gas trapping within the destroyed alveoli…

COPD Nocturnal Desaturator Patients with Obesity and Pulmonary Hypertension: Cross-Talk Between Adipocyte Tissue Systemic Hypoxia and Lung-To-Blood Translocation of Inflammatory Mediators

Chronic obstructive pulmonary disease (COPD) is often accompanied by other chronic diseases associated with systemic inflammation, such as chronic heart…

Bronchial Allergen Challenges in Asthma Research

In the development of new antiallergic or antiasthmatic therapies, mouse models have helped to identify novel therapeutic agents. Before a medication is…

Asthma in Pregnancy

Asthma is a common disease among pregnant women. Uncontrolled asthma may increase the risk of maternal and foetal complications, thus optimal asthma…

Recombinant Allergens in Diagnosis and Therapy of Allergic Diseases

The component-resolved diagnosis use in routine clinical and laboratory practice has increased in recent years. Recombinant allergens can be produced…

Pharmacological Treatment of Idiopathic Pulmonary Fibrosis - An Update

Idiopathic pulmonary fibrosis (IPF) is the most common and most lethal fibrosing interstitial pneumonia, with a mortality rate that exceeds that of many…